Biocon slips despite BBL turning wholly-owned subsidiary
On Monday, Biocon completed the acquisition of 1,15,36,956 equity shares of Biocon Biologics from 127 selling shareholders, making BBL a wholly-owned subsidiary with effect from that date
open_in_new
open_in_new
Read Full Article on Hindu BusinessLine
Original Article
Published on Hindu BusinessLine
● Neutral
Source: Hindu BusinessLine
open_in_new